GRALVSGTBP• 6 Months (Normalized)
GRAL vs GTBP (GRAIL Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GRAL Performance $136.57
+163.95%
GRAIL Inc.
Normalized Baseline0.00%
GTBP Performance $6.88
+1444.94%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1280.99 pts
GTBP outperforming by 1280.99 percentage points
GRALGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GRAL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | GRAL Price | GRAL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $136.57 | +163.95% | $6.88 | +1444.94% | -1280.99% |
| Sep 28, 2026 | $132.63 | +156.34% | $6.80 | +1428.09% | -1271.75% |
| Sep 25, 2026 | $126.89 | +145.25% | $6.89 | +1448.31% | -1303.06% |
| Sep 24, 2026 | $125.21 | +142.00% | $6.83 | +1434.83% | -1292.83% |
| Sep 23, 2026 | $108.52 | +109.74% | $7.10 | +1495.51% | -1385.77% |
| Sep 22, 2026 | $108.52 | +109.74% | $- | - | |
| Sep 21, 2026 | $107.97 | +108.68% | $7.18 | +1513.48% | -1404.80% |
| Sep 18, 2026 | $80.77 | +56.11% | $7.16 | +1508.99% | -1452.88% |
| Sep 17, 2026 | $79.95 | +54.52% | $7.49 | +1583.15% | -1528.63% |
| Sep 16, 2026 | $75.11 | +45.17% | $7.81 | +1655.06% | -1609.89% |
| Sep 15, 2026 | $75.89 | +46.68% | $9.00 | +1922.47% | -1875.79% |
| Sep 14, 2026 | $75.53 | +45.98% | $11.63 | +2513.48% | -2467.50% |
| Sep 11, 2026 | $76.23 | +47.33% | $8.61 | +1834.83% | -1787.50% |
| Sep 10, 2026 | $77.56 | +49.90% | $6.18 | +1288.76% | -1238.86% |
| Sep 09, 2026 | $77.48 | +49.75% | $5.98 | +1243.82% | -1194.07% |
Page 1 of 9